Partners Investment logo

Partners Investment

Asia, Seoul-t'ukpyolsi, South Korea, Seoul

Description

Partners Venture Capital, also known as Partners Investment, is a prominent venture capital firm headquartered in Seoul, South Korea, established in 2000. With a long-standing presence in the Korean startup ecosystem, the firm has positioned itself as a responsible and long-term partner, aiming to contribute constructively to its portfolio companies beyond just capital injection. Their investment philosophy emphasizes fostering innovation and growth by providing strategic guidance and operational support, aligning with their stated goal of being a comprehensive partner to the ventures they support.

The firm maintains a diversified investment strategy, focusing on promising startups across various high-growth sectors. Key areas of interest include Information Technology (IT), Biotechnology (Bio), Content, and New Materials. Partners Venture Capital typically invests across different stages, from early-stage ventures requiring initial capital to growth-stage companies seeking to scale operations. Over its two decades of operation, the firm has built a substantial portfolio, reportedly making over 200 investments and achieving more than 20 successful exits, demonstrating its active role in nurturing and scaling innovative businesses within South Korea and potentially beyond.

Partners Venture Capital has raised and managed multiple significant funds, enabling it to deploy substantial capital into its target companies. For instance, they raised a Partners Growth Investment Fund amounting to approximately ₩150 billion (around $110 million USD at the time of its formation), indicating their capacity for larger investments. While specific first cheque sizes can vary based on the stage and needs of the company, the firm typically provides initial investments ranging from approximately $1.0 million to $7.5 million USD, reflecting its engagement in both early-stage and more mature growth rounds. Their commitment to long-term partnerships underscores their dedication to the sustained success of their portfolio companies.

Investor Profile

Partners Investment has backed more than 32 startups, with 8 new investments in the last 12 months alone. The firm has led 3 rounds, about 9% of its total and boasts 4 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series B, Series A rounds (top funding stages).
  • Majority of deals are located in United States, South Korea, Switzerland.
  • Strong thematic focus on Biotechnology, Health Care, Medical.
  • Led 1 rounds in the past year.
  • Typical check size: $1M – $7.5M.

Stage Focus

  • Series C (31%)
  • Series B (31%)
  • Series A (22%)
  • Series Unknown (9%)
  • Seed (6%)

Country Focus

  • United States (53%)
  • South Korea (41%)
  • Switzerland (3%)
  • Philippines (3%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Biopharma
  • Artificial Intelligence (Ai)
  • Software
  • E-commerce
  • Therapeutics
  • Life Science
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Partners Investment frequently co-invest with?

CJ Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 3
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 4
DSC Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 3
Altitude Life Science Ventures
North America, Colorado, United States, Durango
Co-Investments: 2
UPMC Enterprises
North America, Pennsylvania, United States, Pittsburgh
Co-Investments: 2
T. Rowe Price
North America, Maryland, United States, Baltimore
Co-Investments: 3
Stone Bridge Ventures
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
SJ Investment Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 3
Flagship Pioneering
North America, Massachusetts, United States, Cambridge
Co-Investments: 4
Invus
North America, New York, United States, New York
Co-Investments: 2

Which angels does Partners Investment often collaborate with?

JB
North America, North Dakota, United States, Fargo
Shared Deals: 1

What are some of recent deals done by Partners Investment?

ASWEMAKE

Incheon, Inch'on-jikhalsi, South Korea

ASWEMAKE is a shopping app that delivers groceries.

AppsE-CommerceGroceryRetailShopping
Series CJun 5, 2025
Amount Raised: $7,377,134
Dime Bio

Seongnam, Kyonggi-do, South Korea

Dime Bio is a drug development company for novel dementia treatments.

MedicalPharmaceuticalTest and Measurement
Series AMar 26, 2025
Amount Raised: $8,183,930
Arbor Biotechnologies

Cambridge, Massachusetts, United States

Arbor Biotechnologies is a biotechnology company specializing in next-generation gene editing therapeutics to treat genetic diseases.

BiopharmaBiotechnologyLife Science
Series CMar 18, 2025
Amount Raised: $73,900,000
MediThinQ

Seongnam, Kyonggi-do, South Korea

MediThinQ is a medical technology company that develops and manufactures the eyes up surgical display.

ManufacturingMedicalProduct Design
Series BMar 11, 2025
Amount Raised: $8,549,135
JLT

Seongnam, Kyonggi-do, South Korea

JLT is a company that offers factory automation equipment solutions.

Industrial AutomationManufacturing
Series BFeb 25, 2025
Amount Raised: $16,047,161
Sizzle

Incheon, Inch'on-jikhalsi, South Korea

Sizzle is a company that provides an integrated process analysis solution based on accumulated experience.

DatabaseManufacturing
Series UnknownJan 15, 2025
Amount Raised: $16,287,330
AIGEN Sciences

Seoul, Seoul-t'ukpyolsi, South Korea

AIGEN Sciences is an AI drug discovery platform that provides drug research and development services.

Artificial Intelligence (AI)BiotechnologyPharmaceuticalProduct Research
Series AOct 16, 2024
Amount Raised: $8,794,744
Storelink

Seoul, Seoul-t'ukpyolsi, South Korea

Storelink is an open market optimization platform that analyzes and processes accurate online sales data.

MarketingProduct Research
Series CAug 19, 2024
Amount Raised: $15,010,436
DALPHA

Bongcheondong, Seoul-t'ukpyolsi, South Korea

DALPHA develops 'Customized B2B AI' solutions for enterprises.

Artificial Intelligence (AI)BeautyCloud SecurityContentE-CommerceFashionMarketingSoftware
SeedApr 24, 2024
Amount Raised: $8,710,548
Cytonus Therapeutics

Carlsbad, California, United States

Cytonus is a biotech company combining AI-driven drug discovery together with a class defining drug-delivery platform called the Cargocyte

BiotechnologyHealth CareMedical
Series ANov 3, 2023
Amount Raised: $11,703,095